Clinical Trial Update: Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating the efficacy and safety of Ingavirin for influenza and other acute respiratory viral infections…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Ingavirin

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Common Cold, Influenza | Phase 3 | Status: COMPLETED